TransUnion's high P/S ratio, despite expected average revenue growth, suggests investors are more bullish than analysts. This could risk shareholders' investments and potential investors might pay an unnecessary premium if the P/S aligns with the growth outlook.
TransUnion's investments aren't yielding high returns despite increased capital investment, reflecting in modest stock returns over the past five years. It may not be an ideal choice for those seeking a multi-bagger stock.
CEO Chris Cartwright expressed that these strategic moves aim to maximize the company's operating model, enhance technology, reduce costs, and foster innovation as well as growth. According to him, this reflects the company's ongoing focus on creating shareholder value.
The markets are starting off on the wrong foot. After the weekend commodity and equity markets opened with a sell off. This came following a massive market selloff last week. We have China lockdowns, increasing tensions in Russia, Sri Lanka’s stock market is haunted for two weeks due to a collapse of the economy, and not to mention FED tightening. There is many reasons to be bearish. There are a ton of earnings calls this week that could possibly provide some s...
+1
13
9
2
Report
SpyderCall
OP
:
With this much overextension into the red on the 4 hour candles. We may very well see some green today on Monday. It seem almost impossible but I’ve seen crazier. The indicators are EXTREMELY OVERSOLD ON THE 4 HOUR CANDLES
RDK79
:
Deutsche Bank initiates today at Buy - PT $124. Would have been nice if they’d done this when it was in the low 80s recently. Looks like Deutche is behind the curve, and wondering if their funds bought in the 80s, then initiated the Buy….
$TransUnion (TRU.US)$announced a deal to buy closely held information services company Neustar for $3.1 billion in cash. The credit reporting agency expects the deal to close during the fourth quarter.
TransUnion Stock Forum
$International Flavors & Fragrances (IFF.US)$
$Etsy Inc (ETSY.US)$
$U.S. Bancorp (USB.US)$
$Polaris (PII.US)$
$Wells Fargo & Co (WFC.US)$
$Comcast (CMCSA.US)$
$Teradyne (TER.US)$
$Equifax (EFX.US)$
$Veeva Systems (VEEV.US)$
$TransUnion (TRU.US)$
Can you think of other cheap moat stocks?
$Warren Buffett Portfolio (LIST2999.US)$ $Berkshire Hathaway-A (BRK.A.US)$ $Berkshire Hathaway-B (BRK.B.US)$ $Apple (AAPL.US)$ $Coca-Cola (KO.US)$ $Meta Platforms (META.US)$ $Microsoft (MSFT.US)$ $Alphabet-C (GOOG.US)$ $Alphabet-A (GOOGL.US)$
In reaction to earnings/guidance:
$Liberty Energy (LBRT.US)$ +11.6%, $F5 Inc (FFIV.US)$ +6.9%, $Encore Wire (WIRE.US)$ + 5.6%, $Archer Daniels Midland (ADM.US)$ +5.5%, $Bank of N.T Butterfield & Son (NTB.US)$ +5%, $Albany International (AIN.US)$ +5%, $3M (MMM.US)$ +4.0%,
Other news:
$Shell Midstream (SHLX.US)$ +10% (Shell USA to acquire all units in SHLX held by public at $15.85/unit total value $1.96 bln)
$BridgeBio Pharma (BBIO.US)$...
• $Allstate (ALL.US)$: Raymond James Upgrades to Strong Buy from Outperform - PT $165 (from $145)
• $DigitalBridge Group (DBRG.US)$: JPMorgan Upgrades to Neutral from Underweight - PT $7
• $Garmin (GRMN.US)$: BofA Securities Upgrades to Buy from Neutral - PT $140 (from $165)
• $Guidewire Software (GWRE.US)$: JMP Securities Upgrades to Market Outperform from Market Perform - PT $110
• $MongoDB (MDB.US)$: UBS Upgrades to Buy from Neutral - PT $450 (from $345)...
In reaction to earnings/quidance:
• $Gitlab (GTLB.US)$ +8.8%, $Dole plc (DOLE.US)$ +2.6%, $TransUnion (TRU.US)$ +1.1%
Other news:
- $Hollysys Automation Technologies (HOLI.US)$ +12% (report of takeover interest from a company in China)
- $Anavex Life Sciences (AVXL.US)$ +10.2% (Phase 2 Clinical Biomarker Data from ANAVEX 2-73-PDD-001)
- $Delta Air Lines (DAL.US)$ +4.6% (provides 01 update)
- $Air Transport Services (ATSG.US)$ +4.3% (plac...
$KE Holdings (BEKE.US)$ $Shopify (SHOP.US)$ $Interactive Brokers (IBKR.US)$ $MercadoLibre (MELI.US)$ $TransUnion (TRU.US)$ $Repare Therapeutics (RPTX.US)$ $Surface Oncology (SURF.US)$ $Takeda Pharmaceutical (TAK.US)$ $Teladoc Health (TDOC.US)$ $Vertex Pharmaceuticals (VRTX.US)$ $ROCHE HOLDING AG (RHHBY.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $Novartis AG (NVS.US)$
No comment yet